Furthermore, several experimental studies have made efforts to evaluate the involvement of estrogen receptors and testosterone in GBM malignancy [18, 19] and revealed that female GBM patients generally respond better to standard treatments, including chemotherapy [20, 21] and radiotherapy [22]. This evidence concerns the gene ESR1 and glioblastoma.